Recognition List Number: 029 Publication Date: 08/20/2012
Part B: SUPPLEMENTARY INFORMATION
Recognition Number 7-200: CLSI M48-A, Laboratory Detection and Identification of Mycobacteria; Approved Guideline. (InVitro Diagnostics)
Date of Standard: 2008. |
| Address of Standards Organization: |
| Clinical Laboratory Standards Institute (CLSI) |
| 950 West Valley Road |
| Suite 2500 |
| Wayne, PA 19087 |
| |
|
| CDRH Office and Division Associated with Recognized Standards: |
| OFFICE OF IN VITRO DIAGNOSTICS AND RADIOLOGICAL HEALTH (OIR) | | DIVISION OF MICROBIOLOGY (DMD) |
|
|
| Devices Affected: |
| Mycobacterium tuberculosis immunofluorescent reagents regulated under 21 CFR 866.3370 and Microorganism differentiation and identification device under 21 CFR 866.2600 |
|
| Processes Affected: |
|
| Type of Standard: |
| Vertical, National |
| Extent of Recognition: |
| Partial recognition; Methodology accepted but not interpretive criteria when it differs from those in CDER approved drug package inserts |
|
| Related CFR Citations and Product Codes: |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §866.2660 |
Kit, Identification, Mycobacteria |
Class 1 |
JSY |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §866.3370 |
Antiserum, Fluorescent, Mycobacterium Tuberculosis |
Class 1 |
GRT |
| §866.3370 |
Assay, Nucleic Acid Amplification, Growth Identification, Mycobacterium Tuberculosis |
Class 1 |
NDZ |
| §866.3370 |
Dna-Reagents, Mycobacterium Spp. |
Class 1 |
LQF |
| §866.3370 |
System, Mycolic Acid Analysis, Mycobacterium Tuberculosis |
Class 1 |
NJO |
| |
|
| Relevant Guidance: |
| 1. Review Criteria for Assessment of In Vitro Diagnostic Devices for Direct Detection of Mycobacterium Spp. [Tuberculosis(TB)] |
|
| FDA Technical Contacts: |
| Janice Washington |
| FDA/CDRH/OIVD |
| 10903 New Hampshire Avenue Building 66, Room 5554 |
| Silver Spring MD 20993 |
| 301/796-6207 |
| Email: janice.washington@fda.hhs.gov |
|
| Patricia Conville |
| FDA/CDRH/OIVD |
| 10903 New Hampshire Avenue Building 66, Room 5510 |
| Silver Spring MD 20993 |
| 301/796-6942 |
| Email: patricia.conville@fda.hhs.gov |
|
|